477 related articles for article (PubMed ID: 29953367)
1. Profiles of Radioresistance Mechanisms in Prostate Cancer.
Chaiswing L; Weiss HL; Jayswal RD; Clair DKS; Kyprianou N
Crit Rev Oncog; 2018; 23(1-2):39-67. PubMed ID: 29953367
[TBL] [Abstract][Full Text] [Related]
2. Radioresistant human lung adenocarcinoma cells that survived multiple fractions of ionizing radiation are sensitive to HSP90 inhibition.
Gomez-Casal R; Epperly MW; Wang H; Proia DA; Greenberger JS; Levina V
Oncotarget; 2015 Dec; 6(42):44306-22. PubMed ID: 26517240
[TBL] [Abstract][Full Text] [Related]
3. GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy.
Mukha A; Kahya U; Linge A; Chen O; Löck S; Lukiyanchuk V; Richter S; Alves TC; Peitzsch M; Telychko V; Skvortsov S; Negro G; Aschenbrenner B; Skvortsova II; Mirtschink P; Lohaus F; Hölscher T; Neubauer H; Rivandi M; Labitzky V; Lange T; Franken A; Behrens B; Stoecklein NH; Toma M; Sommer U; Zschaeck S; Rehm M; Eisenhofer G; Schwager C; Abdollahi A; Groeben C; Kunz-Schughart LA; Baretton GB; Baumann M; Krause M; Peitzsch C; Dubrovska A
Theranostics; 2021; 11(16):7844-7868. PubMed ID: 34335968
[TBL] [Abstract][Full Text] [Related]
4. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
[TBL] [Abstract][Full Text] [Related]
5. Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.
Hance MW; Dole K; Gopal U; Bohonowych JE; Jezierska-Drutel A; Neumann CA; Liu H; Garraway IP; Isaacs JS
J Biol Chem; 2012 Nov; 287(45):37732-44. PubMed ID: 22989880
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic mechanisms underlying prostate cancer radioresistance.
Macedo-Silva C; Benedetti R; Ciardiello F; Cappabianca S; Jerónimo C; Altucci L
Clin Epigenetics; 2021 Jun; 13(1):125. PubMed ID: 34103085
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling.
Macedo-Silva C; Miranda-Gonçalves V; Tavares NT; Barros-Silva D; Lencart J; Lobo J; Oliveira Â; Correia MP; Altucci L; Jerónimo C
Signal Transduct Target Ther; 2023 Oct; 8(1):395. PubMed ID: 37840069
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer.
Chen X; Chen F; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
Prostate; 2019 Sep; 79(12):1386-1398. PubMed ID: 31334877
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of epithelial-mesenchymal-transition (EMT) signature and PARP-1 in prostate cancer radioresistance.
Stark TW; Hensley PJ; Spear A; Pu H; Strup SS; Kyprianou N
Prostate; 2017 Dec; 77(16):1583-1591. PubMed ID: 29063620
[TBL] [Abstract][Full Text] [Related]
10. SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties.
Yadav S; Kowolik CM; Lin M; Zuro D; Hui SK; Riggs AD; Horne DA
Mol Carcinog; 2019 Jan; 58(1):113-125. PubMed ID: 30242889
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-498 promotes proliferation, migration, and invasion of prostate cancer cells and decreases radiation sensitivity by targeting PTEN.
Duan XM; Liu XN; Li YX; Cao YQ; Silayiding A; Zhang RK; Wang JP
Kaohsiung J Med Sci; 2019 Nov; 35(11):659-671. PubMed ID: 31332950
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in Prostate Cancer Following Radiotherapy: Towards Predicting Response to Radiation Treatment.
Petrović N; Stanojković TP; Nikitović M
Curr Med Chem; 2022; 29(9):1543-1560. PubMed ID: 34348602
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA GAS5 modulates α-Solanine-induced radiosensitivity by negatively regulating miR-18a in human prostate cancer cells.
Yang J; Hao T; Sun J; Wei P; Zhang H
Biomed Pharmacother; 2019 Apr; 112():108656. PubMed ID: 30970507
[TBL] [Abstract][Full Text] [Related]
14. HSP90 inhibition as a means of radiosensitizing resistant, aggressive soft tissue sarcomas.
Ernst A; Anders H; Kapfhammer H; Orth M; Hennel R; Seidl K; Winssinger N; Belka C; Unkel S; Lauber K
Cancer Lett; 2015 Sep; 365(2):211-22. PubMed ID: 26044951
[TBL] [Abstract][Full Text] [Related]
15. Decreased DAB2IP gene expression, which could be induced by fractionated irradiation, is associated with resistance to γ‑rays and α‑particles in prostate cancer cells.
Yang C; He H; Zhang T; Chen Y; Kong Z
Mol Med Rep; 2016 Jul; 14(1):567-73. PubMed ID: 27177018
[TBL] [Abstract][Full Text] [Related]
16. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
Yao YH; Cui Y; Qiu XN; Zhang LZ; Zhang W; Li H; Yu JM
Chin J Cancer; 2016 Jun; 35():50. PubMed ID: 27266881
[TBL] [Abstract][Full Text] [Related]
17. DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair.
Li Y; Li H; Peng W; He XY; Huang M; Qiu D; Xue YB; Lu L
Mol Med Rep; 2015 Jul; 12(1):1328-34. PubMed ID: 25815686
[TBL] [Abstract][Full Text] [Related]
18. Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma.
Wu H; Yu J; Kong D; Xu Y; Zhang Z; Shui J; Li Z; Luo H; Wang K
Int J Oncol; 2019 Dec; 55(6):1237-1248. PubMed ID: 31638164
[TBL] [Abstract][Full Text] [Related]
19. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse.
Seifert M; Peitzsch C; Gorodetska I; Börner C; Klink B; Dubrovska A
PLoS Comput Biol; 2019 Nov; 15(11):e1007460. PubMed ID: 31682594
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cells in prostate cancer radioresistance.
Tsao T; Beretov J; Ni J; Bai X; Bucci J; Graham P; Li Y
Cancer Lett; 2019 Nov; 465():94-104. PubMed ID: 31493443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
